Explore
Validate
Learn
Western blot
ELISAAntibody data
- Antibody Data
- Antigen structure
- References [6]
- Comments [0]
- Validations
- Western blot [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 16025-1-AP - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#16025-1-AP, RRID:AB_10916385
- Product name
- CST1 antibody
- Antibody type
- Polyclonal
- Description
- KD/KO validated CST1 antibody (Cat. #16025-1-AP) is a rabbit polyclonal antibody that shows reactivity with human and has been validated for the following applications: WB,ELISA.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references Cancer-associated fibroblasts educate normal fibroblasts to facilitate cancer cell spreading and T-cell suppression.
An Extracellular Matrix-Based Signature Associated With Immune Microenvironment Predicts the Prognosis and Therapeutic Responses of Patients With Oesophageal Squamous Cell Carcinoma.
Transcriptional dysregulation of TRIM29 promotes colorectal cancer carcinogenesis via pyruvate kinase-mediated glucose metabolism.
Proteomic profiling of human decidual immune proteins during Toxoplasma gondii infection.
Elevated expression of CST1 promotes breast cancer progression and predicts a poor prognosis.
Differential secretome analysis reveals CST6 as a suppressor of breast cancer bone metastasis.
Itoh G, Takagane K, Fukushi Y, Kuriyama S, Umakoshi M, Goto A, Yanagihara K, Yashiro M, Tanaka M
Molecular oncology 2022 Jan;16(1):166-187
Molecular oncology 2022 Jan;16(1):166-187
An Extracellular Matrix-Based Signature Associated With Immune Microenvironment Predicts the Prognosis and Therapeutic Responses of Patients With Oesophageal Squamous Cell Carcinoma.
Zhang H, Shi Q, Yang Z, Wang K, Zhang Z, Huang Z, Cui X, Li F
Frontiers in molecular biosciences 2021;8:598427
Frontiers in molecular biosciences 2021;8:598427
Transcriptional dysregulation of TRIM29 promotes colorectal cancer carcinogenesis via pyruvate kinase-mediated glucose metabolism.
Han J, Zhao Z, Zhang N, Yang Y, Ma L, Feng L, Zhang X, Zuo J, Fan Z, Wang Y, Song Y, Wang G
Aging 2021 Jan 20;13(4):5034-5054
Aging 2021 Jan 20;13(4):5034-5054
Proteomic profiling of human decidual immune proteins during Toxoplasma gondii infection.
Zhang D, Sun X, Ren L, Yang C, Liu X, Zhang H, Jiang Y, Hu X
Journal of proteomics 2018 Aug 30;186:28-37
Journal of proteomics 2018 Aug 30;186:28-37
Elevated expression of CST1 promotes breast cancer progression and predicts a poor prognosis.
Dai DN, Li Y, Chen B, Du Y, Li SB, Lu SX, Zhao ZP, Zhou AJ, Xue N, Xia TL, Zeng MS, Zhong Q, Wei WD
Journal of molecular medicine (Berlin, Germany) 2017 Aug;95(8):873-886
Journal of molecular medicine (Berlin, Germany) 2017 Aug;95(8):873-886
Differential secretome analysis reveals CST6 as a suppressor of breast cancer bone metastasis.
Jin L, Zhang Y, Li H, Yao L, Fu D, Yao X, Xu LX, Hu X, Hu G
Cell research 2012 Sep;22(9):1356-73
Cell research 2012 Sep;22(9):1356-73
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The CST1 antibody from Proteintech is a rabbit polyclonal antibody to a recombinant protein of human CST1. This antibody recognizes human antigen. The CST1 antibody has been validated for the following applications: ELISA, WB analysis.
